The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationRole of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Most patients with T2DM who are not using insulin are probably being treated with metformin, which might be cancer-protective”
BackgroundPlasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Self-citationHyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583 · cited 1×
“For example, in both Costello syndrome and cardiofaciocutaneous syndromes, RAS and RAF mutations are associated with thyroid, colorectal and ovarian tumors”
BackgroundRole of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Giovannucci, E. (1995) · Cancer Causes and Control · doi:10.1007/bf00052777 · Cited by 817
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 782
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
Tidyman, W. E., & Rauen, K. A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.001 · Cited by 780
(2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70095-4 · Cited by 652
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Biological Mechanisms Linking Obesity and Cancer Risk: New Perspectives
Roberts, D. L., Dive, C., & Renehan, A. G. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.080708.082713 · Cited by 610
Self-citationHemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., & Baserga, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11217 · Cited by 553
Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3604 · Cited by 538
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
SUIKKARI, A.-M., KOIVISTO, V. A., RUTANEN, E.-M., YKI-JÄRVINEN, H., KARONEN, S.-L., & SEPPÄLÄ, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-266 · Cited by 483
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Self-citationDunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Central obesity and breast cancer risk: a systematic review
Harvie, M., Hooper, L., & Howell, A. H. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00108.x · Cited by 391
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
Yang, Y., Hennessy, S., & Lewis, J. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.011 · Cited by 350
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
Brems, H., Beert, E., de Ravel, T., & Legius, E. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70033-6 · Cited by 349
Olmos, D., Postel-Vinay, S., Molife, L. R., Okuno, S. H., Schuetze, S. M., Paccagnella, M. L., Batzel, G. N., Yin, D., Pritchard-Jones, K., Judson, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70354-7 · Cited by 340
Roddam, A., Allen, N. E., Appleby, P. N., Key, T. J., Ferrucci, L., Carter, H. B., Metter, E. J., Chen, C., Weiss, N. S., Fitzpatrick, A. L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00006 · Cited by 331
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 320
Does diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 314
Sklar, C. A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3136 · Cited by 310
Tolcher, A. W., Sarantopoulos, J., Patnaik, A., Papadopoulos, K., Lin, C.-C., Rodon, J., Murphy, B., Roth, B., McCaffery, I., Gorski, K. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6745 · Cited by 308
Long-term safety of recombinant human growth hormone in children
Bell, J., Parker, K. L., Swinford, R. D., Hoffman, A. R., Maneatis, T., & Lippe, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0178 · Cited by 301
Swerdlow, A., Higgins, C., Adlard, P., & Preece, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09519-3 · Cited by 291
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Insulin promotion of colon tumors in rats.
Tran, T. T., Medline, A., & Bruce, W. R. (1996) · PubMed · Cited by 275
Growth Hormone Treatment and Risk of Second Neoplasms in the Childhood Cancer Survivor
Ergun-Longmire, B., Mertens, A. C., Mitby, P., Qin, J., Heller, G., Shi, W., Yasui, Y., Robison, L. L., & Sklar, C. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0656 · Cited by 274
Gualberto, A., & Pollak, M. (2009) · Oncogene · doi:10.1038/onc.2009.172 · Cited by 274
Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., & Hintz, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36715-7 · Cited by 272
Lopez, T., & Hanahan, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00055-7 · Cited by 268
Obesity and colorectal cancer risk: A meta-analysis of cohort studies
Dai, Z. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i31.4199 · Cited by 267
Nava, C., Hanna, N., Michot, C., Pereira, S., Pouvreau, N., Niihori, T., Aoki, Y., Matsubara, Y., Arveiler, B., Lacombe, D., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.050450 · Cited by 256
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Acromegaly and gastrointestinal cancer
Ron, E., Gridley, G., Hrubec, Z., Page, W., Arora, S., & Fraumeni, J. F. (1991) · Cancer · doi:10.1002/1097-0142(19911015)68:8<1673::aid-cncr2820680802>3.0.co;2-0 · Cited by 250
FANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia
Deans, A. J., & West, S. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.006 · Cited by 247
Blethen, S. L., Allen, D. B., Graves, D., August, G., Moshang, T., & Rosenfeld, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626820 · Cited by 246
Rinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 244
Chernausek, S. D., Backeljauw, P. F., Frane, J., Kuntze, J., Underwood, L. E., & for the GH Insensitivity Syndrome Collaborative Group (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1610 · Cited by 243
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry
Rosenberg, P. S., Alter, B. P., & Ebell, W. (2008) · Haematologica · doi:10.3324/haematol.12234 · Cited by 214
Wennbo, H., Gebre-Medhin, M., Gritli-Linde, A., Ohlsson, C., Isaksson, O. G., & Törnell, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119820 · Cited by 207
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Yakar, S., LeRoith, D., & Brodt, P. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.010 · Cited by 200
Kaaks, R., Lundin, E., Manjer, J., Rinaldi, S., Biessy, C., Söderberg, S., Lenner, P., Janzon, L., Riboli, E., Berglund, G., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1015270324325 · Cited by 198
Kim, K., Bae, S. K., Lee, O., Bae, M.-H., Lee, M. J., & Park, B. C. (1998) · PubMed · Cited by 190
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II)
Bates, P., Fisher, R., Ward, A., Richardson, L., Hill, D., & Graham, C. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.484 · Cited by 187
Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor Recurrence
Swerdlow, A. J., Reddingius, R. E., Higgins, C. D., Spoudeas, H. A., Phipps, K. P., Qiao, Z., Ryder, W. D. J., Brada, M., Hayward, R. D., Brook, C. G. D., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7044 · Cited by 183
Acromegaly and cancer risk: a cohort study in Sweden and Denmark
Baris, D., Gridley, G., Ron, E., Weiderpass, E., Mellemkjaer, L., Ekbom, A., Olsen, J. H., Baron, J. A., & Fraumeni, J. F. (2002) · Cancer Causes & Control · doi:10.1023/a:1015713732717 · Cited by 176
Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik, R. A., Borofsky, N. D., Massardo, S., & Orentreich∥, N. (2002) · PubMed · Cited by 161
Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
Yang, X., Beamer, W. G., Huynh, H. T., & Pollak, M. (1996) · PubMed · Cited by 157
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 155
Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor
Zhang, D., Bar‐Eli, M., Meloche, S., & Brodt, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313145200 · Cited by 152
Heuson, J.-C., & Legros, N. (1972) · PubMed · Cited by 151
Insulin glargine and malignancy: an unwarranted alarm
Pocock, S., & Smeeth, L. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61307-6 · Cited by 150
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Home, P., & Lagarenne, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1530-5 · Cited by 144
Diabetes and Risk of Non-Hodgkin's Lymphoma
Mitri, J., Castillo, J. J., & Pittas, A. G. (2008) · Diabetes Care · doi:10.2337/dc08-1034 · Cited by 142
Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J. P., Hramiak, I., Johnston, P., & Davis, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1452-2 · Cited by 141
Insulin injections promote the growth of aberrant crypt foci in the colon of rats
Corpet, D. E., Jacquinet, C., Peiffer, G., et al. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514543 · Cited by 139
Jones, R. A., Campbell, C. I., Gunther, E. J., Chodosh, L. A., Petrik, J., Khokha, R., & Moorehead, R. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209955 · Cited by 135
Adipose tissue in health and disease
Harvey, I. C., Boudreau, A., & Stephens, J. M. (2020) · Open Biology · doi:10.1098/rsob.200291 · Cited by 133
Mortality and GH deficiency: a nationwide study
Stochholm, K., Gravholt, C. H., Laursen, T., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt‐Rasmussen, U., Christiansen, J. S., Frydenberg, M., & Green, A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0013 · Cited by 132
Noonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway
Tidyman, W. E., & Rauen, K. A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000902 · Cited by 127
Romano, A. A., Dana, K., Bakker, E., Davis, D. A., Hunold, J. J., Jacobs, J. R., & Lippe, B. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2094 · Cited by 126
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
Pollak, M., Blouin, M.-J., Zhang, J.-C., & Kopchick, J. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1895 · Cited by 123
Christofori, G., Naik, P., & Hanahan, D. (1995) · Nature Genetics · doi:10.1038/ng0695-196 · Cited by 121
Renehan, A. G., O’Connell, J., O’Halloran, D., Shanahan, F., Potten, C. S., O’Dwyer, S., & Shalet, S. M. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814150 · Cited by 119
Self-citationWolf, E., Kramer, R., Blum, W. F., Föll, J., & Brem, G. (1994) · Endocrinology · doi:10.1210/endo.135.5.7525257 · Cited by 119
Oncogenic Transformation of Human Mammary Epithelial Cells by Autocrine Human Growth Hormone
Zhu, T., Emerald, B. S., Zhang, X., Lee, K., Gluckman, P. D., Mertani, H. C., & Lobie, P. E. (2005) · Cancer Research · doi:10.1158/0008-5472.317.65.1 · Cited by 118
Moorehead, R. A., Sanchez, O. H., Baldwin, R. M., & Khokha, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206188 · Cited by 116
Acromegaly, growth hormone and cancer risk
Renehan, A. G., & Brennan, B. M. D. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.011 · Cited by 114
Self-citationRecent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan
Nishi, Y., Tanaka, T., Takano, K., Fujieda, K., Igarashi, Y., Hanew, K., Hirano, T., Yokoya, S., Tachibana, K., Saito, T., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5716 · Cited by 113
Autocrine Stimulation of Human Mammary Carcinoma Cell Proliferation by Human Growth Hormone
Kaulsay, K. K., Mertani, H. C., Törnell, J., Morel, G., Lee, K., & Lobie, P. E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4492 · Cited by 111
Keinan‐Boker, L., Bueno-de-Mesquita, H. B., Kaaks, R., van Gils, C. H., van Noord, P. A. H., Rinaldi, S., Ríboli, E., Seidell, J. C., Grobbee, D. E., & Peeters, P. H. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11193 · Cited by 110
Dejgaard, A., Lynggaard, H., Råstam, J., & Thomsen, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1568-4 · Cited by 109
Ormandy, C. J. (2005) · Breast Cancer Online · doi:10.1017/s1470903105004475 · Cited by 105
Disproportionate growth in mice with Igf-2 transgenes.
Ward, A., Bates, P., Fisher, R., Richardson, L., & Graham, C. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10365 · Cited by 102
Risk of leukemia in children treated with human growth hormone: Review and reanalysis
Allen, D. B., Rundle, A. C., Graves, D. A., & Blethen, S. L. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70008-8 · Cited by 102
Jorge, A. A. L., Malaquias, A. C., Arnhold, I. J. P., & Mendonca, B. B. (2009) · Hormone Research in Paediatrics · doi:10.1159/000201106 · Cited by 100
Mira, E., Mañes, S., Lacalle, R. A., Márquez, G., & Martínez‐A, C. (1999) · Endocrinology · doi:10.1210/endo.140.4.6623 · Cited by 100
Lee, O.-H., Bae, S. K., Bae, M., Lee, Y. M., Moon, E., J, H., Kwon, Y., & Kim, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0931 · Cited by 99
Sachdev, D., Zhang, X., Matise, I., Gaillard-Kelly, M., & Yee, D. (2009) · Oncogene · doi:10.1038/onc.2009.316 · Cited by 99
Growth hormone safety update from the National Cooperative Growth Study.
Maneatis, T. J., Baptista, J., Connelly, K. A., & Blethen, S. L. (2000) · PubMed · Cited by 93
Silha, J. V., Sheppard, P. C., Mishra, S., Gui, Y., Schwartz, J., Dodd, J. G., & Murphy, L. J. (2006) · Endocrinology · doi:10.1210/en.2005-1270 · Cited by 90
Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation
Núñez, N. P., Oh, W., Rozenberg, J. M., Perella, C., Anver, M. R., Barrett, J. C., Perkins, S. L., Berrigan, D. A., Moitra, J., Varticovski, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4102 · Cited by 88
Karna, E., Surażyński, A., Orłowski, K., Łaszkiewicz, J., Puchalski, Z., Nawrat, P., & Palka, J. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00237.x · Cited by 84
Ramsey, M. M., Ingram, R. L., Cashion, A. B., Ng, A. H., Cline, J. M., Parlow, A. F., & Sonntag, W. E. (2002) · Endocrinology · doi:10.1210/en.2002-220717 · Cited by 84
Tuffli, G. A., Johanson, A. J., Rundle, A. C., & Allen, D. B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714117 · Cited by 84
Wu, J. D., Haugk, K. H., Coleman, I. M., Woodke, L. B., Vessella, R. L., Nelson, P. S., Montgomery, B., Ludwig, D. L., & Plymate, S. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0443 · Cited by 84
van Buul-Offers, S. C., de Haan, K., Gresnigt, M. G., Meinsma, D., Jansen, M., Sl, O., Bonte, E. J., Sussenbach, J. S., & den Brande, J. L. V. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1440491 · Cited by 82
Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
Larsson, S. C., Andersson, S., Johansson, J., & Wolk, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.012 · Cited by 82
Böni-Schnetzler, M., Schmid, C., Mary, J.-L., Zimmerli, B., Meier, P. J., Zapf, J., Schwander, J., & Froesch, E. R. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-9-1320 · Cited by 80
Swanson, S. M., & Unterman, T. G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.977 · Cited by 77
Morris, J. K., George, L., Wu, T., & Wald, N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603200 · Cited by 71
Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations
Denayer, E., Devriendt, K., de Ravel, T. J. L., Buggenhout, G. V., Smeets, E., François, I., Sznajer, Y., Craen, M., Leventopoulos, G., Mutesa, L., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20735 · Cited by 71
Midyett, L. K., Rogol, A. D., Meter, Q. L. V., Frane, J. W., & Bright, G. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0570 · Cited by 71
Rho, S. B., Dong, S. M., Kang, S., Seo, S., Yoo, C. W., Lee, D. O., Woo, J. S., & Park, S. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn206 · Cited by 70
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling
Zhang, X., Mehta, R. G., Lantvit, D., Coschigano, K. T., Kopchick, J. J., Green, J. E., Hedayat, S., Christov, K. T., Ray, V., Unterman, T. G., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl138 · Cited by 69
Modulation of the immune response and tumor growth by activated Ras
Weijzen, S., Velders, M. P., & Kast, W. M. (1999) · Leukemia · doi:10.1038/sj.leu.2401367 · Cited by 67
Colao, A. A. L., Pivonello, R., Auriemma, R. S., Galdiero, M., Ferone, D., Minuto, F. M., Marzullo, P., & Lombardi, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2551 · Cited by 63
Leukemia in Growth-Hormone Treated Patients: An Update, 1992
Stahnke, N. (2008) · Hormone Research · doi:10.1159/000182571 · Cited by 60
Lessons from the national cooperative growth study
Wyatt, D. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151s055 · Cited by 57
Törnell, J., Rymo, L., & Isaksson, O. G. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490121 · Cited by 56
Slater, M., Cooper, M. J. W., & Murphy, C. R. (2006) · Acta Histochemica · doi:10.1016/j.acthis.2006.01.004 · Cited by 55
Gil, C., Seoane, S., Blanco, M. M. V., Macia, M., García‐Caballero, T., Segura, C., & Pérez-Fernández, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01962 · Cited by 54
Anzo, M., Cobb, L. J., Hwang, D., Mehta, H. H., SAID, J. W., Yakar, S., LeRoith, D., & Cohen, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3165 · Cited by 54
Xu, X. Q., Emerald, B. S., Goh, E. L. K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503869200 · Cited by 52
Kimura, T., Kuwata, T., Ashimine, S., Yamazaki, M., Yamauchi, C., Nagai, K., Ikehara, A., Feng, Y., Dimitrov, D. S., Saito, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0982 · Cited by 50
IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies
Chen, B., Liu, S., Xu, W., et al. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-89 · Cited by 48
Heuson, J.-C., Gaver, C. W.-V., & Legros, N. (1970) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(70)90031-9 · Cited by 46
Morbidity and GH deficiency: a nationwide study.
Stochholm, K., Laursen, T., Green, A., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M., & Gravholt, C. H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0523 · Cited by 44
The effect of cigarette smoking use and cessation on serum insulin-like growth factors
Renehan, A. G., Atkin, W. S., O’Dwyer, S., & Shalet, S. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602150 · Cited by 42
Self-citationValidation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
Yuen, J. S. P., Akkaya, E., Wang, Y., Takiguchi, M., Peak, S., Sullivan, M., Protheroe, A. S., & Macaulay, V. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0101 · Cited by 42
Diehl, D., Hessel, E., Oesterle, D., Renner‐Müller, I., Elmlinger, M. W., Langhammer, M., Göttlicher, M., Wolf, E., Lahm, H., & Hoeflich, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.24193 · Cited by 37
Koohestani, N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1679 · Cited by 37
Safety aspects of GH replacement
Svensson, J., & Bengtsson, B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0287 · Cited by 36
Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation
Deitel, K., Dantzer, D., Ferguson, P. C., et al. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10136 · Cited by 35
Does growth hormone treatment affect the risk of post-transplant renal cancer?
Mehls, O., Wilton, P., Lilien, M., Berg, U., Broyer, M., Rizzoni, G., Waldherr, R., & Opelz, G. (2002) · Pediatric Nephrology · doi:10.1007/s00467-002-0962-7 · Cited by 32
Growth Hormone Treatment and Cancer Risk
Banerjee, I., & Clayton, P. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.007 · Cited by 31
Self-citationAdipose Tissue in Health and Disease
Leff, T., & Granneman, J. G. (2010) · Wiley eBooks · doi:10.1002/9783527629527 · Cited by 25
Hong, S., Briggs, J., Newman, R. J., Hoffman, K. E., Mendoza, A., LeRoith, D., Helman, L. J., Yakar, S., & Khanna, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24169 · Cited by 20
Chung, T., Evanson, J., Walker, D., Akker, S. A., BESSER, G. M., Monson, J. P., Grossman, A. B., & Drake, W. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03135.x · Cited by 19
Sharon, R., Pillemer, G., Ish‐Shalom, D., Kalman, R., Ziv, E., Berry, E. M., & Naor, D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530523 · Cited by 18
Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues.
Ressler, S., Radhi, J. M., Aigner, T. G., Loo, C. K. C., Zwerschke, W., & Sergi, C. M. (2009) · PubMed · Cited by 18
Growth Hormone and Neurofibromatosis
Howell, S. J., Wilton, P., Lindberg, A., & Shalet, S. M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053208 · Cited by 17
Renehan, A. G., Egger, M., & Zwahlen, M. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002020012 · Cited by 10
Self-citation
Cited by
Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Adiposity and cancer risk: new mechanistic insights from epidemiology
Renehan, A. G., Zwahlen, M., & Egger, M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3967 · Cited by 654
Self-citationObesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
Ma, Y., Yang, Y., Wang, F., Zhang, P., Shi, C., Zou, Y., & Qin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053916 · Cited by 622
Wigmore, T. J., Mohammed, K., & Jhanji, S. (2016) · Anesthesiology · doi:10.1097/aln.0000000000000936 · Cited by 510
Metadata
- Authors
- Clayton, P. E., Banerjee, I., Murray, P. G., & Renehan, A. G.
- Venue
- Nature Reviews Endocrinology
- Published
- 2010-10-19
- Volume
- 7
- Issue
- 1
- Pages
- 11-24
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2069115947
- Cited by
- 364
- References
- 154
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.